The Transfusion News email arrived today. As
always there were some useful snippets:
Zika Virus RNA Can Shed for More Than 6 Months in Semen from Some Infected Men
April 18, 2018
The Zika virus (ZIKV), which has now spread to at least 48 countries including the United States, is associated with adverse birth outcomes. While commonly transmitted by Aedes mosquitoes, ZIKV transmission may also occur via other modes including via transfusion and sexual routes. Since sexual transmission may pose a greater risk to growing fetuses, researchers [Read More]
April 18, 2018The Zika virus (ZIKV), which has now spread to at least 48 countries including the United States, is associated with adverse birth outcomes. While commonly transmitted by Aedes mosquitoes, ZIKV transmission may also occur via other modes including via transfusion and sexual routes. Since sexual transmission may pose a greater risk to growing fetuses, researchers [Read More]
Costs are High for Administrating Blood Transfusions
April 11, 2018A recent micro-costing study in the United Kingdom suggests administration costs are high for blood transfusions. Researchers collected detailed data on key inputs for blood transfusions for all laboratory supplies and staff time, including all laboratory personal and nurses at two large hospitals in Oxford and Reading. The cost of wasted blood products was also [Read More]
Secondary Bacterial Culture for Platelets Reduces Transfusion Risk and Complies with FDA Draft Guidance for Platelet Safety
April 4, 2018
Platelets are most susceptible to bacterial contamination due to their storage conditions. In order to decrease the risk of bacterial contamination, in 2016, the FDA issued a draft guidance suggesting additional safety measures beyond a primary bacterial culture for platelets—namely pathogen reduction or secondary bacterial testing. Pathogen reduction and point-of-release [Read More]
April 4, 2018Platelets are most susceptible to bacterial contamination due to their storage conditions. In order to decrease the risk of bacterial contamination, in 2016, the FDA issued a draft guidance suggesting additional safety measures beyond a primary bacterial culture for platelets—namely pathogen reduction or secondary bacterial testing. Pathogen reduction and point-of-release [Read More]
No comments:
Post a Comment